Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-28T15:26:32.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page has been updated to include new drug information related to breast cancer treatments, specifically mentioning Doxorubicin, Epirubicin, Cyclophosphamide, and endocrine therapy, while significant details about the study involving pembrolizumab have been removed.
    Difference
    15%
    Check dated 2025-04-21T11:08:19.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-07T03:21:04.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-03-30T21:38:55.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-03-02T03:50:11.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The website has updated to revision v2.14.2, noting that some NLM-NCBI services are experiencing heavy traffic, which may impact performance and availability.
    Difference
    0.5%
    Check dated 2025-02-06T17:26:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.